Pharmaceuticals - Union Register


Register of orphan medicinal products


Product information


EU orphan designation number: EU/3/10/842   
Active ingredient: Nimorazole
Indication: Treatment of squamous cell carcinoma of the head and neck in patients undergoing radiotherapy
Sponsor: Azanta A/S
Gearhalsvej 1, 2500 Valby, Danmark

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
1/03/2011 Orphan designation EMA/OD/093/10 (2011)1308 of 23/02/2011
5/08/2016 Change of name and/or address of sponsor